Skip to main content
Toggle navigation
Search
Home
Benefit design and management
Home
Benefit design and management
Benefit design and management
Type here to filter the list
(9) Improving Access and Equity in the United States Through a Uniform National Formulary
(10) Economic impact of early vs. late initiation of atogepant for the preventive treatment of migraine
(11) Patient perspectives on health insurance design: Experiences of beneficiaries with chronic diseases
(12) Patient Perspectives on Employer-Based Health Insurance: Experiences of Employees with Chronic Diseases
(13) Implications of Wegovy® utilization in the New York State Medicaid Program
(14) Impact of a Medical Claims Automated Glucagon Like Peptide-1 Drugs Prior Authorization Program
(15) Payer Expectations for the Impact of MFP Pricing on Management and Profitability
(16) The Impact of Copay Accumulators and Maximizers on Treatment Patterns and Costs Among Patients with Major Depressive and Bipolar Disorders Treated with Branded Mental Health Treatments
(17) Does time on market influence the evidence cited in U.S. commercial health plan specialty drug coverage policies?
(18) Assessing commercial health plan responsiveness to FDA label changes
(19) Estimating the Budget Impact of Prevalence-Adjusted Willingness to Pay Thresholds Using the Generalized Dynamic Prevalence (GDP) Theory
(20) Trends in commercial payer coverage of accelerated approval therapies
(21) Managed care insights on optimizing coverage coordination for therapies spanning medical and pharmacy benefits
